Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$45.73 - $69.19 $163,850 - $247,907
-3,583 Reduced 39.34%
5,525 $338,000
Q1 2024

May 13, 2024

SELL
$40.38 - $50.75 $120,332 - $151,235
-2,980 Reduced 24.65%
9,108 $450,000
Q4 2023

Feb 13, 2024

BUY
$24.89 - $43.41 $8,910 - $15,540
358 Added 3.05%
12,088 $507,000
Q3 2023

Nov 08, 2023

BUY
$30.02 - $38.81 $70,516 - $91,164
2,349 Added 25.04%
11,730 $381,000
Q2 2023

Jul 31, 2023

BUY
$26.7 - $37.02 $881 - $1,221
33 Added 0.35%
9,381 $331,000
Q1 2023

May 12, 2023

BUY
$26.64 - $39.74 $3,036 - $4,530
114 Added 1.23%
9,348 $265,000
Q4 2022

Jan 19, 2023

BUY
$38.78 - $46.78 $98,307 - $118,587
2,535 Added 37.84%
9,234 $384,000
Q3 2022

Nov 01, 2022

BUY
$30.9 - $50.65 $4,604 - $7,546
149 Added 2.27%
6,699 $278,000
Q2 2022

Jul 29, 2022

BUY
$29.23 - $44.45 $191,456 - $291,147
6,550 New
6,550 $214,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.62B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.